New products of interest to pediatricians
John Browning, MD, explains dermatological questions to ask, answer in primary care
John Browning, MD, highlights why pediatricians should feel comfortable prescribing recent non-steroidals, and what questions to ask patients in office.
Food Insecurity and the Dangers of Infant Formula Dilution
A headache with a red flag in a 10-year-old girl
The patient described the headache as “pressure-like,” episodes that occurred for 1 to 2 hours with high severity.
Demystifying Infant Formula
Olivia is helping patients and families understand the experience of blood cancer
Phase 3 trial of omaveloxolone to treat Friedreich ataxia in children aged 2 to <16 begins
Currently, omaveloxolone (Skyclarys) is approved to treat adults and adolescents aged 16 years and older impacted by FA.